#D25TS_Picks #TTEK: $40.65 Record Q3 net revenue of $1.11B (+8% YoY) and a surging $4.49B backlog highlight strong growth from global water infrastructure and environmental modernization spending. Resistance: $42.5, $46 | Support: $39.3 For Detailed Analysis: https://t.me/c/2454754655/10750 #AMAT: $391 Q3 revenue up 25% YoY to $9.12B with >70% advanced packaging growth highlights market leadership across AI chip manufacturing and major fab expansions. Resistance: $400, $413 | Support: $381.80 For Detailed Analysis: https://t.me/c/2454754655/10072 #SMMT: $17.83 Superior Phase 3 survival data over pembrolizumab and a $2B strategic investment from AstraZeneca highlight high-conviction growth ahead of key FDA decisions. Resistance: $19.25, $21 | Support: $16.55 For Detailed Analysis: https://t.me/c/2454754655/10734 🚀 Join our ThinkSabio Stocks WL999 Group To join, simply visit our ThinkSabio Community Page or access the ThinkSabio Bot. 🌐 https://www.thinksabio.com/community D25.jpg